Holger Lingel

507 total citations
21 papers, 353 citations indexed

About

Holger Lingel is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Holger Lingel has authored 21 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 6 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Holger Lingel's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (10 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Holger Lingel is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (10 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Holger Lingel collaborates with scholars based in Germany, United Kingdom and United States. Holger Lingel's co-authors include Monika C. Brunner‐Weinzierl, Maike de la Roche, Douglas T. Fearon, Anja Hoffmann, James Thaventhiran, Łukasz Magiera, Mandy Pierau, Kathrin Chamaon, Jonathan A. Lindquist and Burkhart Schraven and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Holger Lingel

20 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holger Lingel Germany	11	182	113	96	38	37	21	353
Aoi Shiomi Japan	6	160 0.9×	53 0.5×	87 0.9×	35 0.9×	16 0.4×	7	354
Toshiyuki Ikemoto Japan	10	136 0.7×	64 0.6×	77 0.8×	22 0.6×	46 1.2×	35	355
Wangko Lundström Sweden	6	208 1.1×	81 0.7×	88 0.9×	18 0.5×	25 0.7×	8	397
Sara E. Vazquez United States	8	140 0.8×	53 0.5×	104 1.1×	17 0.4×	25 0.7×	20	389
Jasmin Grählert Switzerland	5	148 0.8×	58 0.5×	89 0.9×	14 0.4×	18 0.5×	5	274
Annaïse Jauch Switzerland	5	334 1.8×	108 1.0×	138 1.4×	22 0.6×	7 0.2×	9	507
Maryam Behfar Iran	10	156 0.9×	69 0.6×	141 1.5×	24 0.6×	5 0.1×	68	415
Noëmie Pörtner Belgium	11	133 0.7×	65 0.6×	127 1.3×	12 0.3×	17 0.5×	21	319
Ana B. Pavel United States	12	103 0.6×	40 0.4×	59 0.6×	59 1.6×	54 1.5×	19	534

Countries citing papers authored by Holger Lingel

Since Specialization

Citations

This map shows the geographic impact of Holger Lingel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Lingel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Lingel more than expected).

Fields of papers citing papers by Holger Lingel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Lingel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Lingel. The network helps show where Holger Lingel may publish in the future.

Co-authorship network of co-authors of Holger Lingel

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Lingel. A scholar is included among the top collaborators of Holger Lingel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Lingel. Holger Lingel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lokau, Juliane, Yvonne Garbers, Manuel M. Vicente, et al.. (2025). Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection. Frontiers in Immunology. 15. 1488745–1488745. 4 indexed citations

Schmidt, Julien, et al.. (2025). SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade. Frontiers in Immunology. 16. 1654374–1654374.

Lingel, Holger, Laura Fischer, Benno Kuropka, et al.. (2024). SLAMF7 (CD319) on activated CD8+ T cells transduces environmental cues to initiate cytotoxic effector cell responses. Cell Death and Differentiation. 32(3). 561–572. 2 indexed citations

Salerno, Fiamma, Andrew J.M. Howden, Louise S. Matheson, et al.. (2023). An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells. Nature Communications. 14(1). 5116–5116. 13 indexed citations

Lingel, Holger, Denny Schanze, Martin Zenker, et al.. (2023). Bifidobacteria shape antimicrobial T-helper cell responses during infancy and adulthood. Nature Communications. 14(1). 5943–5943. 11 indexed citations

Lingel, Holger, et al.. (2023). PD-1/PD-L1 Control of Antigen-Specifically Activated CD4 T-Cells of Neonates. International Journal of Molecular Sciences. 24(6). 5662–5662. 5 indexed citations

Morhart, Patrick, Sven Kehl, Wolfgang Schuh, et al.. (2023). Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens. In Vivo. 37(1). 70–78. 3 indexed citations

Lingel, Holger, et al.. (2023). PD-1 limits differentiation and plasticity of Tc17 cells. Frontiers in Immunology. 14. 1104730–1104730. 9 indexed citations

Reinhold, Annegret, Jacqueline Färber, Hans‐Gert Heuft, et al.. (2022). IL‐13 determines specific IgE responses and SARS‐CoV‐2 immunity after mild COVID‐19 and novel mRNA vaccination. European Journal of Immunology. 52(12). 1972–1979. 10 indexed citations

10.

Lingel, Holger, Dirk Roggenbuck, Thomas Hachenberg, et al.. (2021). Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. Journal of Autoimmunity. 122. 102682–102682. 36 indexed citations

11.

Fu, Hang, Holger Lingel, Christian Beyer, et al.. (2021). Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adults. OncoImmunology. 10(1). 1938475–1938475. 5 indexed citations

12.

Fu, Hang, Mandy Pierau, Jonathan A. Lindquist, et al.. (2020). Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up‐Regulation of Cold‐Shock Y‐Box Binding Protein 1. Arthritis & Rheumatology. 72(10). 1721–1733. 7 indexed citations

13.

Lingel, Holger & Monika C. Brunner‐Weinzierl. (2019). CTLA-4 (CD152): A versatile receptor for immune-based therapy. Seminars in Immunology. 42. 101298–101298. 63 indexed citations

14.

Lingel, Holger, Josef Wissing, Denny Schanze, et al.. (2017). CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death and Differentiation. 24(10). 1739–1749. 35 indexed citations

15.

Lingel, Holger, Benno Kuropka, Thomas Fischer, et al.. (2017). The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs. OncoImmunology. 6(2). e1273300–e1273300. 15 indexed citations

16.

Reichl, Udo, Holger Lingel, Monika C. Brunner‐Weinzierl, et al.. (2016). Early changes in the metabolic profile of activated CD8+ T cells. BMC Cell Biology. 17(1). 28–28. 30 indexed citations

17.

Lingel, Holger, Johannes Kolja Hegel, Magdalena Huber, et al.. (2014). CTLA‐4 (CD152) enhances the Tc17 differentiation program. European Journal of Immunology. 44(7). 2139–2152. 10 indexed citations

18.

Šmída, Michal, Holger Lingel, Luca Simeoni, et al.. (2013). PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells. Cell Communication and Signaling. 11(1). 28–28. 9 indexed citations

19.

Thaventhiran, James, Anja Hoffmann, Łukasz Magiera, et al.. (2012). Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8 ⁺ T cell. Proceedings of the National Academy of Sciences. 109(33). E2223–9. 65 indexed citations

20.

Lingel, Holger, et al.. (2012). Migration of Th1 Lymphocytes Is Regulated by CD152 (CTLA-4)-Mediated Signaling via PI3 Kinase-Dependent Akt Activation. PLoS ONE. 7(3). e31391–e31391. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact